THE DEAL, AT A GLANCE
From the announcementTempo Therapeutics
01What happenedTempo Therapeutics raised $15M Series B, announced 2026-09-16From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersTempo Therapeutics' $15M Series B is a below-median Healthcare & Life Sciences financing, sitting at the 20th percentile in a sector that recorded 30 other trailing…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Tempo Therapeutics · Financing Record
Explore source-linked visual explanations for Tempo Therapeutics. Unsupported claims are withheld while source review continues.
Record 12428 · Recorded date: 2026-09-16
What it does
Tempo Therapeutics is a biotechnology and tissue engineering company based out of San Diego, CA specializing in speeding up patient recovery.
Source: tempothera.com ↗